INMB SG&A Expense Growth
Inmune Bio Inc · SG&A Expense Growth
INMB SG&A Expense Growth
Latest reported8.19%period ending
INMB FY SG&A Growth (YoY) (0.00% → 8.19%)
Latest values, visible window
High-resolution chart · PNG
INMB sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 8.1936% | |
| -1.4548% | |
| 3.9425% | |
| 5.3123% | |
| 39.0761% | |
| 41.2812% | |
| -50.7534% | |
| 1,563.5599% | |
| 333.4407% | |
| 157.8293% | |
| 0% |